A role for p53 in the β-amyloid-mediated regulation of the lysosomal system

Neurobiology of Aging

Volumn 31, Issue 10, 2010, Pages 1774-1786

  Fogarty, Marie P ^a   McCormack, Róisín M ^a   Noonan, Janis ^a   Murphy, Declan ^a   Gowran, Aoife ^a   Campbell, Veronica A ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Amyloid; Apoptosis; Lysosome; P53

Indexed keywords

AMYLOID BETA PROTEIN; CATHEPSIN L; PIFITHRIN ALPHA; PROTEIN BAX; PROTEIN P53; SMALL INTERFERING RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; LYSOSOME; LYSOSOME MEMBRANE; MALE; NERVE CELL CULTURE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BENZOTHIAZOLES; CATHEPSIN L; CELL CULTURE TECHNIQUES; CEREBRAL CORTEX; LYSOSOMES; MALE; NEURONS; PHOSPHOPROTEINS; RATS; RATS, WISTAR; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77955841088     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.09.018     Document Type: Article

References (48)

1. Adamec E., Mohan P.S., Cataldo A.M., Vonsattel J.P., Nixon R.A. Up-regulation of the lysosomal system in experimental models of neuronal injury: implications for Alzheimer's disease. Neuroscience 2000, 100:663-675.
2. 2 is a consequence of lysosomal rupture. Biochem. J. 2001, 356:549-555.
3. Boland B., Campbell V. β-Amyloid (1-40)-induced apoptosis of cultured cortical neurones involves calpain-mediated cleavage of poly-ADP-ribose polymerase. Neurobiol. Aging 2003, 24:179-186.
4. Boland B., Campbell V. Aβ-mediated activation of the apoptotic cascade in cultured cortical neurones: a role for cathepsin-L Neurobiol. Aging 2004, 25:83-91.
5. Boya P., Andreau K., Poncet D., Zamzami N., Perfettini J.L., Metivier D., Ojcius D.M., Jaattela M., Kroemer G. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J. Exp. Med. 2003, 197:1323-1334.
6. Boya P., Gonzalez-Polo R.A., Poncet D., Andreau K., Vieira H.L., Roumier T., Perfettini J.L., Kroemer G. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 2003, 22:3927-3936.
7. Brunk U.T., Svensson I. Oxidative stress, growth factor starvation and Fas activation may all cause apoptosis through lysosomal leak. Redox Rep. 1999, 4:3-11.
8. Chen C.S., Chen W.N., Zhou M., Arttamangkul S., Haugland R.P. Probing the cathepsins using a BODIPY FL-pepstatin A: applications in florescence polarization and microscopy. J. Biochem. Biophys. Meth. 2000, 42:137-151.
9. Chipuk J.E., Kuwana T., Bouchier-Hayes L., Droin N.M., Newmeyer D.D., Schuler M., Green D.R. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004, 303:1010-1014.
10. Chua C.C., Liu X., Gao J., Hamdy R.C., Chua B.H.L. Multiple actions of pifithrin-α on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells A. J. Physiol. Heart Circ. Physiol. 2006, 290:H2606-H2613.
11. Culmsee C., Zhu X., Yu Q.-S., Chan S.L., Camandola S., Guo Z., Greig N.H., Mattson M.P. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid β-peptide. J. Neurochem. 2001, 77:220-228.
12. Finucane D.M., Bossy-Wetzel E., Waterhouse N.J., Cotter T.G., Green D.R. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xl. J. Biol. Chem. 1999, 274:2225-2233.
13. Fogarty M.P., Downer E.J., Campbell V. A role for c-jun N terminal kinase 1 (JNK1), but not JNK2, in the β-amyloid-mediated stabilization of protein p53 and induction of the apoptotic cascade in cultured cortical neuron. Biochem. J. 2003, 371:789-798.
14. Giovanni A., Keramaris E., Morris E.J., Hou S.T., O'Hare M., Dyson N., Robertson G.S., Slack R.S., Park D.S. E2F1 mediates death of β-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase-3. J. Biol. Chem. 2000, 275(16):11553-11560.
15. Glenner G.G., Wong C.W. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Comm. 1984, 122:1131-1135.
16. Gowran A., Campbell V.A. A role for p53 in the regulation of lysosomal permeability by Δ9-tetrahydrocannabinol in rat cortical neurones: implications for neurodegeneration. J. Neurochem. 2008, 105:1513-1524.
17. Gudkov A.V., Komarova E.A. Prospective therapeutic applications of p53 inhibitors. Biochem. Biophys. Res. Commun. 2005, 331:726-736.
18. Hitami J., Katayama T., Eguchi Y., Kudo T., Taniguchi M., Koyama Y., Manabe T., Yamagishi S., Bando Y., Imaizumi K., Tsujimoto Y., Tohyama M. Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Aβ-induced cell death. J. Cell Biol. 2004, 165:347-356.
19. Ishisaka R., Utsumi T., Kanno T., Arita K., Katunuma N., Akiyama J., Utsemi K. Participation of a cathepsin-L-type protease in the activation of caspase-3. Cell Struct. Funct. 1999, 24:465-470.
20. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of Aβ42 and Aβ40 in senile plaques with end-specific β monoclonals: evidence that an initially deposited species is Aβ42. Neuron 1994, 13:45-53.
21. Ji Z.-S., Miranda R.D., Newhouse Y.M., Weisgraber K.H., Hunag Y., Mahley R.W. Apolipoprotein E4 potentiates amyloid β peptide-induced lysosomal leakage and apoptosis in neuronal cells. J. Biol. Chem. 2002, 277:21821-21828.
22. Ji Z.S., Mullendorff K., Cheng I.H., Miranda R.D., Huang Y., Mahley R.W. reactivity of apolipoprotein E4 and β-amyloid: lysosomal stability and neurodegeneration. J. Biol. Chem. 2006, 281(5):2683-2692.
23. Kagedal K., Johansson A.C., Johansson U., Heimlich G., Roberg K., Wang N.S., Jurgensmeier J.M., Ollinger K. Lysosomal membrane permeabilization during apoptosis: involvement of Bax?. Int. J. Exp. Pathol. 2005, 86(5):309-321.
24. Kitamura Y., Shimohama S., Kamoshima W., Matsuoka Y., Nomura Y., Taniguchi T. Changes of p53 in the brains of patients with Alzheimer's disease. Biochem. Biophys. Res. Commun. 1997, 232:418-421.
25. Komarov P.G., Komarova E.A., Kondratov R.V., Christov-Tselkov K., Coon J.S., Chernov M.V., Gudkov A.V. A chemical inhibitor of p53 that protects mice from the side effects of cancer. Science 1999, 285:1733-1737.
26. Komarova E.A., Neznanov N., Komarov P.G., Gudkov A. p53 inhibior, PFT-alpha can suppress heat shock and glucocorticold signalling pathways. J. Biol. Chem. 2003, 278:15465-15468.
27. Laferla F.M., Hall C.K., Ngo L., Jay G. Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice. J. Clin. Invest. 1996, 98:1232-1626.
28. Lin N., Zheng Y., Chen W., Wang C., Lui X., He W., Xu H., Cao X. Adaptor protein LAPF recruits phosphorylated p53 to lysosomes and triggers lysosomal destabilization in apoptosis. Cancer Res. 2007, 67:11176-11185.
29. MacGibbon G.A., Lawlor P.A., Sirimanne E.S., Walton M.R., Connor B., Young D., Williams C., Gluckman P., Faull R.L., Hughes P., Dragunow M. Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. Brain Res. 1997, 750:223-234.
30. (1-40) in rat cortical synaptosomes and cultured cortical neurones: modulation by the proinflammatory cytokine interleukin-1β. J. Biol. Chem. 2000, 275(5):4713-4718.
31. Mihara M., Erster S., Zaika A., Petrenko O., Chittenden T., Pancoska P., Moll U.M. p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 2003, 11:577-590.
32. Miyashita T., Reed J.C. Tumour suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80:293-299.
33. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B.A., Yuan J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by β-amyloid. Nature 2000, 403:98-103.
34. Paradis E., Douillard H., Koutroumanis M., Goodyer C., LeBlanc A. Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates Bax expression in human neurons. J. Neurosci. 1996, 16:7533-7539.
35. Pompl P.N., Yemul S., Xiang Z., Ho L., Haroutunian V., Purohit D., Mohs R., Pasinetti G.M. Caspase gene expression in the brain as a function of the clinical progression in Alzheimer's disease. Arch. Neurol. 2003, 60:369-376.
36. Schuler M., Green D.R. Mechanisms of p53-dependent apoptosis. Biochem. Soc. Trans. 2001, 29:684-688.
37. Sedarous M., Keramaris E., O'Hare M., Melloni E., Slack R.S., Elce J.S., Greer P.A., Park D.S. Calpains mediate p53 activation and neuronal death evoked by DNA damage. J. Biol. Chem. 2003, 278(28):26031-26038.
38. Slee E.A., Harte M.T., Kluck R.M., Wolf B.B., Casiano C.A., Newmeyer D.D., Wang H.G., Reed J.C., Nicholson D.W., Alnemri E.S., Green D.R., Martin S.J. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 1999, 144:281-292.
39. Stoka V., Turk B., Schendel S.L., Kim T.H., Cirman T., Snipas S.J., Ellerby L.M., Bredensen D., Abrahamson M., Bromme D., Krajewski S., Reed J.C., Yin X.M., Turk V., Salvesen G.S. Lysosomal protease pathways to apoptosis. Cleavage of bid, not pre-caspases, most likely route. J. Biol. Chem. 2001, 276:3149-3157.
40. Troy C.M., Rabacchi S.A., Friedman W.J., Frappier T.F., Brown K., Shelanski M.L. Caspase-2 mediates neuronal cell death induced by β-amyloid. J. Neurosci. 2000, 20:1386-1392.
41. Uetsuki T., Takemoto K., Nishimura I., Okamoto M., Niinobe M., Momoi T., Miura M., Yoshikawa K. Activation of neuronal caspase-3 by intracellular accumulation of wild-type Alzheimer amyloid precursor protein. J. Neurosci. 1999, 19:6955-6964.
42. Wang S.Q., Du Q.S., Zhao K., Li A.X., Wei D.Q., Chou K.C. Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy. Amino Acids 2007, 33:129-135.
43. White A.R., Guirguis R., Brazier M.W., Jobling M.F., Hill A.F., Beyreuther K., Barrow C.J., Master C.L., Collins S.J., Cappai R. Sublethal concentration of prion peptide PrP106-126 or the amyloid peptide protein of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons. Neurobiol. Dis. 2001, 8:299-316.
44. Yamashima T., Tonchev A.B., Tsukada T., Saido T.C., Imajoh-Ohmi S., Momoi T., Kominami E. Sustained capain activation associated with lysosomal rupture executes necrosis of the postischemic CAI neurons in primates. Hippocampus 2003, 13(7):791-800.
45. Yoshida T., Tomioka I., Nagahara T., Holyst T., Sawada M., Hayes P., Gama V., Okuno M., Chen Y., Abe Y., Kanouchi T., Sasada H., Wang D., Yokota T., Sato E., Matsuyama S. Bax-inhibiting peptide derived from mouse and rat Ku70. Biochem. Biophys. Res. Commun. 2004, 321:961-966.
46. Yuan X.-M., Li W., Dalen H., Lotem J., Kama R., Sachs L., Brunk U.T. Lysosomal destabilization in p53-induced apoptosis. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:6286-6291.
47. 1-42 through p53 and Bax in cultured primary human neurons. J. Cell Biol. 2002, 156:519-529.
48. Zhao M., Eaton J.W., Brunk U.T. Bcl-2 phosphorylation is required for inhibition of oxidative stress-induced lysosomal leak and ensuing apoptosis. FEBS Lett. 2001, 14:405-412.